Background Clinical and radiographic criteria are traditionally used to determine the need
for surfactant therapy in preterm infants. Lung ultrasound is a bedside test that offers a rapid …

Background: Less invasive surfactant administration (LISA) has become the preferred
method of surfactant administration for spontaneously breathing babies on continuous …

Lung ultrasound (LU) has emerged as the imaging technique of choice for the assessment
of neonates with respiratory distress syndrome (RDS) at the bedside. Scoring systems were …

In the realm of emergency medicine, the swift adoption of lung ultrasound (LU) has extended
from the adult population to encompass pediatric and neonatal intensivists. LU stands out as …

Surfactant is a pivotal neonatal drug used both for respiratory distress syndrome due to
surfactant deficiency and for more complex surfactant dysfunctions (such as in case of …

Extremely preterm infants frequently require some form of respiratory assistance to facilitate
the cardiopulmonary transition that occurs in the first hours of life. Current resuscitation …

Lung disease is often life-threatening for both preterm and term newborns. Therefore, an
accurate and rapid diagnosis of lung diseases in newborns is crucial, as management …

Objective Timely application of surfactant replacement therapy is critical for neonates with
respiratory distress syndrome (RDS). Presently, early clinical decision on surfactant use …

Objective Lung ultrasound is a useful tool for diagnosis and follow-up of diseases in critically
ill neonates. Its use is increasingly widespread thanks to its advantages over other imaging …

Lung ultrasound (LUS) is useful for diagnosis of respiratory distress syndrome in neonates.
Recently, it has been proved to play an important role in the management of neonatal …